Despite growing public alarm over the shrinking Greenland and Antarctic ice sheets, it is small glaciers and ice caps that have been contributing the most to rising sea levels in recent years, according to a new University of Colorado at Boulder study.
In the first test of a new radar instrument, scientists have seen through more than a mile of Greenland ice to reveal an image of land that has been hidden for millions of years. Ohio State University scientists and their colleagues will use what they learn from the instrument, dubbed GISMO (for Global Ice Sheet Mapping Orbiter), to determine how global climate change will affect the ice.
Researchers at the University of Texas M. D. Anderson Cancer Center reported today that MK-0457 (VX-680), a novel multi-kinase inhibitor, is clinically active against multiple target mutations in two types of leukemia and myeloproliferative disorders, and produces few side effects for patients.
High-resolution observations from Hubble have shed light on the real mass of a star previously believed to be amongst the heaviest known in our Milky Way. Originally, the mass of the star was thought to be an incredible 200-300 solar masses, but turned out to be only 100 solar masses.
Even a small-scale, regional nuclear war could produce as many direct fatalities as all of World War II and disrupt the global climate for a decade or more, with environmental effects that could be devastating for everyone on Earth. A team of scientists at Rutgers University, the University of Colorado at Boulder and UCLA conducted rigorous scientific studies reported at an AGU press conference today.
Thalidomide is a widely prescribed treatment for multiple myeloma. However, an estimated 15 to 30 percent of patients suffer venous thromboembolisms (VTEs), blood clots, as a major complication. The Bank On A Cure DNA-bank researchers have identified four gene clusters associated with the VTEs. Identifying the associated single nucleotide polymorphisms (SNPs) for use as markers, may lead to the development of screenings and tailored interventions to prevent these side effects, as a major step toward personalized medicine.
Mayo Clinic Cancer Center, in collaboration with researchers from the University of Iowa, today presented results of a Phase II clinical study indicating that an oral drug, tipifarnib, can stall or reverse disease progression for patients with relapsed aggressive non-Hodgkin lymphoma.
Even a small-scale, regional nuclear war could produce as many direct fatalities as all of World War II and disrupt the global climate for a decade or more, with environmental effects that could be devastating for everyone on Earth. A team of scientists at Rutgers University, the University of Colorado at Boulder and UCLA conducted rigorous scientific studies reported at an AGU press conference today.
In a study of more than 36,000 women, researchers observed that smokers can reduce their risk of developing lung cancer by being physically active. However, they strongly caution that any relative benefit is dwarfed by the benefits gained from quitting smoking.
Mayo Clinic Cancer Center, working in collaboration with Ohio State University Comprehensive Cancer Center, presented evidence Sunday that a novel regimen of three chemotherapy drugs, pentostatin, cyclophosphamide and rituximab, resulted in significant clinical response in patients with previously untreated chronic lymphocytic leukemia (CLL).